Exodus Point Capital Management, LP Zynerba Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.5 - $0.72 $9,794 - $14,103	19,588 Added 134.6%	34,141 $18,000
Q3 2022 Nov 10, 2022	SELL	$0.87 - $1.36 $2,937 - $4,591	-3,376 Reduced 18.83%	14,553 $11,000
Q2 2022 Aug 19, 2022	SELL	$0.86 - $2.06 $5,844 - $13,999	-6,796 Reduced 27.49%	17,929 $20,000
Q1 2022 May 13, 2022	SELL	$1.83 - $3.02 $41,969 - $69,260	-22,934 Reduced 48.12%	24,725 $51,000
Q4 2021 Feb 11, 2022	BUY	$2.88 - $4.3 $69,675 - $104,029	24,193 Added 103.1%	47,659 $137,000
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $76,933 - $110,643	-20,681 Reduced 46.85%	23,466 $99,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $99,963 - $156,078	26,100 Added 144.62%	44,147 $234,000
Q1 2021 May 17, 2021	BUY	$3.33 - $8.76 $60,096 - $158,091	18,047 New	18,047 $84,000
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $535,311 - $712,643	-165,731 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $548,569 - $1.08 Million	165,731 New	165,731 $559,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.16 $38,541 - $81,866	-13,290 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $74,556 - $113,895	13,290 New	13,290 $80,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.